Search research articles
Contact Us
Filters
Showing results (91-100 of 140) with videos related to
Page
of 14
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 9, 2023
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer
Sherry Shen, Weining Ma, David Brown, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 10, 2025
A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)
Ramez N Eskander, Bradley Corr, David Cibula, et al.
Gynecologic Oncology
|
October 15, 2023
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer
Sileny N Han, Amit Oza, Nicoletta Colombo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 7, 2025
Erratum to 'Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101651]
Christian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 7, 2025
Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma
Christian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi, et al.
Gynecologic Oncology
|
March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate
Paul Johannet, Matthew Flint, M Herman Chui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2020
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Vicky Makker, Matthew H Taylor, Carol Aghajanian, et al.
Gynecologic Oncology
|
November 3, 2020
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers
Maria M Rubinstein, Rachel N Grisham, Karen Cadoo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary
Lindsey Finch, Sarah Andres, Alexia Iasonos, et al.
Gynecologic Oncology
|
March 13, 2025
The genomic landscape of distant metastatic endometrial cancer
William A Zammarrelli, Subhiksha Nandakumar, Elizabeth Kertowidjojo, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 140) with videos related to
Sort By:
Page
of 14
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 9, 2023
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer
Sherry Shen, Weining Ma, David Brown, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 10, 2025
A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)
Ramez N Eskander, Bradley Corr, David Cibula, et al.
Gynecologic Oncology
|
October 15, 2023
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer
Sileny N Han, Amit Oza, Nicoletta Colombo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 7, 2025
Erratum to 'Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101651]
Christian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 7, 2025
Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma
Christian Dagher, Pernille Bjerre Trent, Rofieda Alwaqfi, et al.
Gynecologic Oncology
|
March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate
Paul Johannet, Matthew Flint, M Herman Chui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2020
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Vicky Makker, Matthew H Taylor, Carol Aghajanian, et al.
Gynecologic Oncology
|
November 3, 2020
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers
Maria M Rubinstein, Rachel N Grisham, Karen Cadoo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary
Lindsey Finch, Sarah Andres, Alexia Iasonos, et al.
Gynecologic Oncology
|
March 13, 2025
The genomic landscape of distant metastatic endometrial cancer
William A Zammarrelli, Subhiksha Nandakumar, Elizabeth Kertowidjojo, et al.
Page
of 14